Aspen Buys Nestle Infant-Nutrition in Australia, Africa

Aspen Pharmacare Holdings Ltd., the largest maker of generic medicines in the southern Hemisphere, agreed to buy licenses to sell Nestle SA’s infant formula in Australia and southern African countries for $215 million.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.